DIA510.29+3.24 0.64%
SPY756.78+2.18 0.29%
QQQ738.26+2.66 0.36%

Nano-X Imaging Signs Distribution Agreement With Radiology Oncology Systems To Expand Nanox.Arc Adoption In The U.S.

Benzinga·04/23/2026 12:17:34
Listen to the news

Nano-X Imaging Ltd. (("Nanox", or the "Company", NASDAQ:NNOX), a leader in innovative medical imaging technology, today announced that its U.S.-based subsidiary, Nanox Impact Inc., has signed a distribution agreement with Radiology Oncology Systems, a U.S. provider of diagnostic imaging and oncology equipment solutions serving hospitals and clinics nationwide, to distribute its Nanox.ARC systems across the U.S.
Under the terms of the agreement, Radiology Oncology Systems will support the commercial rollout of the Nanox.ARC, an FDA-cleared, multisource digital tomosynthesis system that makes 3D imaging possible in more clinical settings, at a lower cost and reduced radiation dose compared to traditional CT. Radiology Oncology Systems has a strong track record of supporting U.S. hospitals and clinics with reliable, cost-effective technologies designed to expand access to imaging and oncology-related clinical applications.
Through this collaboration, Nanox and Radiology Oncology Systems aim to broaden access to advanced imaging solutions across additional U.S. clinical settings, including oncology-adjacent care environments. The agreement includes the planned deployment of Nanox.ARC systems, leveraging Radiology Oncology Systems' established distribution network and service infrastructure to support deployment.
"We continue to systematically expand our U.S. commercial footprint through targeted distribution agreements," said Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox. "Radiology Oncology Systems adds another experienced partner to our growing U.S. network, bringing specialized expertise in oncology and diagnostic imaging that complements our existing channel partners and supports measured deployment and continued commercial execution."
John Vano, President and Chief Executive Officer of Radiology Oncology Systems, said, "We are pleased to enter into this agreement with Nanox. We believe the Nanox.ARC aligns well with our focus on delivering practical, accessible imaging solutions to U.S. healthcare providers."
This agreement represents another step in Nanox's expanding U.S. distribution strategy, as the company continues to advance its channel partner strategy, building a diversified distribution network to support commercial deployment across the United States.

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.